Peak Pharmaceuticals, Inc. (PKPH)
Peak Pharmaceuticals, Inc. operates in the Shell Companies industry of the Financial Services sector, headquartered in Scottsdale, AZ, US. The stock last traded at $1.55, up 0.00% on the session, giving a market capitalisation of $607,316. Its beta of 0.56 implies it has historically moved less than the broad market.
Peak Pharmaceuticals, Inc., an American bio-pharmaceutical and nutraceutical company, specializes in the development, manufacturing, marketing, and sale of therapeutic products derived from hemp extracts. The firm particularly concentrates on formulating over-the-counter, THC-free, hemp-based remedies for human application, designed to help prevent and mitigate symptoms linked to inflammatory and auto-immune conditions. Originally established in 2007 as Cannabis Therapy Corporation, the company rebranded to Peak Pharmaceuticals, Inc. in December 2014 and maintains its main office in Scottsdale, Arizona.
Peak Pharmaceuticals, Inc. is most often compared with the following Financial Services names: